Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 17,878,594 | +17,878,594 | $0 | $207.03M | 14.29% | +$207.03M |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 1,950,000 | -180,000 | $16.29M | $165.56M | 11.42% | +$149.26M |
| EyePoint, Inc.(EYPT) | 8,325,000 | 8,325,000 | 0 | $78.34M | $118.55M | 8.18% | +$40.21M |
| Rapport Therapeutics, Inc.(RAPP) | 2,940,921 | 3,192,521 | +251,600 | $33.44M | $94.82M | 6.54% | +$61.38M |
| BridgeBio Pharma, Inc.(BBIO) | 1,600,000 | 1,400,000 | -200,000 | $69.09M | $72.72M | 5.02% | +$3.63M |
| Edgewise Therapeutics, Inc.(EWTX) | 4,251,992 | 4,010,000 | -241,992 | $55.74M | $65.04M | 4.49% | +$9.30M |
| Bright Minds Biosciences Inc.(DRUG) | 1,059,331 | 1,059,331 | 0 | $27.66M | $64.26M | 4.43% | +$36.60M |
| Arcellx Inc COMMON STOCK | 800,000 | 775,000 | -25,000 | $52.68M | $63.63M | 4.39% | +$10.95M |
| Insmed Incorporated(INSM) | 540,000 | 430,000 | -110,000 | $54.35M | $61.92M | 4.27% | +$7.58M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,175,000 | 2,175,000 | 0 | $39.39M | $61.86M | 4.27% | +$22.47M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,625,000 | 1,000,000 | -625,000 | $68.33M | $53.00M | 3.66% | -$15.33M |
| Centessa Pharmaceuticals PlcADS | 2,086,600 | 1,925,000 | -161,600 | $27.42M | $46.68M | 3.22% | +$19.26M |
| Pharvaris N V COM | 1,454,660 | 1,363,200 | -91,460 | $25.60M | $34.01M | 2.35% | +$8.41M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,375,000 | 2,375,000 | 0 | $16.39M | $30.04M | 2.07% | +$13.66M |
| GH Research PLC(GHRS) | 2,009,482 | 1,916,439 | -93,043 | $24.50M | $27.41M | 1.89% | +$2.91M |
| CG Oncology, Inc.(CGON) | 625,000 | 625,000 | 0 | $16.25M | $25.18M | 1.74% | +$8.93M |
| Korro Bio, Inc.(KRRO) | 465,000 | 465,000 | 0 | $5.81M | $22.27M | 1.54% | +$16.46M |
| MBX Biosciences, Inc.(MBX) | 700,000 | 1,225,000 | +525,000 | $7.99M | $21.44M | 1.48% | +$13.45M |
| Metsera Inc | 400,000 | 400,000 | 0 | $11.38M | $20.93M | 1.44% | +$9.55M |
| Janux Therapeutics, Inc.(JANX) | 1,500,000 | 850,000 | -650,000 | $34.65M | $20.77M | 1.43% | -$13.88M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 300,000 | 300,000 | 0 | $12.15M | $17.83M | 1.23% | +$5.68M |
| Crinetics Pharmaceuticals In | 400,000 | 400,000 | 0 | $11.50M | $16.66M | 1.15% | +$5.16M |
| Engene Holdings Inc COM | 2,323,595 | 2,323,595 | 0 | $8.46M | $15.87M | 1.10% | +$7.41M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,000,000 | 775,000 | -225,000 | $14.02M | $14.61M | 1.01% | +$588.8K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 1,994,173 | -6,499,978 | $400.92M | $14.30M | 0.99% | -$386.63M |
| Avidity Biosciences Inc | 200,000 | 300,000 | +100,000 | $5.68M | $13.07M | 0.90% | +$7.39M |
| BioAge Labs, Inc.(BIOA) | 2,140,605 | 2,140,605 | 0 | $8.84M | $12.59M | 0.87% | +$3.75M |
| Axsome Therapeutics, Inc.(AXSM) | 100,000 | 100,000 | 0 | $10.44M | $12.14M | 0.84% | +$1.71M |
| Cabaletta Bio, Inc.(CABA) | 5,000,000 | 5,000,000 | 0 | $7.60M | $11.70M | 0.81% | +$4.10M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 533,340 | +533,340 | $0 | $10.26M | 0.71% | +$10.26M |
| Alumis Inc | 2,147,396 | 2,147,396 | 0 | $6.44M | $8.57M | 0.59% | +$2.13M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $6.43M | $7.21M | 0.50% | +$785.6K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 500,000 | +500,000 | $0 | $6.79M | 0.47% | +$6.79M |
| Vaxcyte, Inc.(PCVX) | 175,000 | 175,000 | 0 | $5.69M | $6.30M | 0.43% | +$614.3K |
| Enliven Therapeutics Inc | 200,000 | 200,000 | 0 | $4.01M | $4.09M | 0.28% | +$82.0K |
| Biohaven Ltd.(BHVN) | 10,000 | 10,000 | 0 | $141.1K | $150.1K | 0.01% | +$9.0K |
| Aardvark Therapeutics Inc | 800,189 | 0 | -800,189 | $10.82M | $0 | — | -$10.82M |
| ARS Pharmaceuticals, Inc.(SPRY) | 1,100,000 | 0 | -1,100,000 | $19.20M | $0 | — | -$19.20M |
| Cargo Therapeutics Inc | 3,381,277 | 0 | -3,381,277 | $13.93M | $0 | — | -$13.93M |
| Helix Acquisition Corp IiCL A | 2,909,000 | 0 | -2,909,000 | $30.89M | $0 | — | -$30.89M |
| KALA BIO, Inc.(KALA) | 603,027 | 0 | -603,027 | $2.87M | $0 | — | -$2.87M |
| Merus N V | 1,120,000 | 0 | -1,120,000 | $58.91M | $0 | — | -$58.91M |
| Stoke Therapeutics, Inc.(STOK) | 254,161 | 0 | -254,161 | $2.88M | $0 | — | -$2.88M |
| Verona Pharma PlcADS | 350,000 | 0 | -350,000 | $33.10M | $0 | — | -$33.10M |
| Yarrow Bioscience Inc(YARW) | 1,370,938 | 0 | -1,370,938 | $2.26M | $0 | — | -$2.26M |